TD Asset Management
TXG icon

TD Asset Management’s 10x Genomics TXG Stock Holding History

TD Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-131,680
Closed -$1.89M – 1274
2024
Q4 		$1.89M Sell
131,680
-126,478
-49% -$2M ﹤0.01% 1026
2024
Q3 		$5.85M Sell
258,158
-26,406
-9% -$546K 0.01% 763
2024
Q2 		$5.53M Sell
284,564
-95,000
-25% -$2.49M 0.01% 741
2024
Q1 		$14.2M Buy
379,564
+104,400
+38% +$4.59M 0.01% 560
2023
Q4 		$15.4M Buy
275,164
+36,800
+15% +$1.6M 0.02% 526
2023
Q3 		$9.83M Buy
238,364
+100,382
+73% +$5.22M 0.01% 590
2023
Q2 		$7.7M Sell
137,982
-6,348
-4% -$344K 0.01% 657
2023
Q1 		$8.05M Buy
144,330
+34,982
+32% +$1.63M 0.01% 638
2022
Q4 		$3.98M Sell
109,348
-20,900
-16% -$683K ﹤0.01% 797
2022
Q3 		$3.9M Buy
130,248
+72,100
+124% +$2.75M ﹤0.01% 811
2022
Q2 		$2.63M Sell
58,148
-4,385
-7% -$228K ﹤0.01% 928
2022
Q1 		$4.76M Buy
62,533
+2,538
+4% +$222K ﹤0.01% 836
2021
Q4 		$8.94M Buy
59,995
+4,806
+9% +$736K 0.01% 708
2021
Q3 		$8.03M Buy
55,189
+30
+0.1% +$5.15K 0.01% 699
2021
Q2 		$10.1M Buy
55,159
+15,306
+38% +$2.77M 0.01% 643
2021
Q1 		$7.21M Buy
39,853
+2,624
+7% +$453K 0.01% 726
2020
Q4 		$5.27M Buy
37,229
+12,990
+54% +$1.89M 0.01% 777
2020
Q3 		$3.02M Buy
24,239
+4,795
+25% +$503K ﹤0.01% 827
2020
Q2 		$1.74M Buy
19,444
+4,000
+26% +$312K ﹤0.01% 912
2020
Q1 		$962K Buy
15,444
+5,800
+60% +$453K ﹤0.01% 1007
2019
Q4 		$735K Sell
9,644
-2,763
-22% -$166K ﹤0.01% 1168
2019
Q3 		$625K Buy
+12,407
New +$687K ﹤0.01% 1142

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TD Asset Management's TXG Position: Q1 2025 in Review

TD Asset Management sold out of 10x Genomics (TXG) in Q1 2025, closing a stake of 131,680 shares — an estimated $1.89M sold.

TD Asset Management first reported a position in TXG in Q3 2019 and held it in 22 quarters. The position peaked at $15.4M in Q4 2023. 274 funds tracked by Wall St. Rank hold TXG as of Q1 2025.

  • TD Asset Management reported no remaining 10x Genomics position as of Q1 2025 after selling out during the quarter.
  • TD Asset Management sold 131,680 10x Genomics shares in Q1 2025, an estimated $1.89M.
  • TD Asset Management first reported a position in 10x Genomics in Q3 2019 and held it in 22 quarters.
  • TD Asset Management's 10x Genomics position peaked at $15.4M in Q4 2023.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2025.

Based on TD Asset Management's 13F filing for Q1 2025, filed 7 May 2025.